PTPI 8-K 2026-09-30

Petros Pharmaceuticals, Inc. (PTPI) 8-K dated 2026-09-30 — accession 0001104659-26-112399. This URL is the filing, not the PTPI hub.

Petros Pharmaceuticals, Inc. (PTPI) is a drug manufacturers - specialty & generic company listed on US.

Petros Pharmaceuticals, Inc. filed a 8-K on 2026-09-30. Accession 0001104659-26-112399.

Cached items: 1.03, 2.04, 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PTPI revenue for 2024-12-31 was $5.1M. Net income was -$14.3M. Revenue was down 12.2% from 2023-12-31 to 2024-12-31. PTPI currently screens at market cap $233.0K and trailing P/E 0.0.

Not investment advice. The PTPI SEC hub lists recent forms. The stock page is the research view.